QDEL logo

QDEL QuidelOrtho Corporation

NASDAQ Global Select · Medical - Instruments & Supplies · Healthcare

$14.30
-0.79 (-5.24%)

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracki…

Market Cap: $975.13Mwww.quidelortho.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 10Aug 10

Quote

Day Range
$14.11 – $15.25
52-Week Range
$9.92 – $35.58
Volume
$866.2K
Market Cap
$975.13M
50-Day Avg
$15.75
200-Day Avg
$20.18
Prev Close
$15.09
Open
$14.79

Valuation & Ratios

P/E Ratio
-1.76
EPS
$-16.69
P/B Ratio
1.03
P/S Ratio
0.73
Debt/Equity
1.48
Current Ratio
1.50
Dividend Yield
+0.0%
Gross Margin
+46.7%

Returns & Efficiency

Return on Equity
-58.9%
Return on Assets
-19.6%
FCF Yield
-4.2%
EV/EBITDA
-9.53

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.73B$-1.13B$-16.69
2024$2.78B$-2.05B$-30.54
2023$3.00B$-10.10M$-0.15
2022$3.27B$548.70M$9.66
2021$1.70B$704.20M$16.74

Social Signal Score

50
5d
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Wed, Nov 4(in 3 months)

Consensus estimate $0.18 per share

6of 7 quarters beat consensus

Typical surprise +17.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.13 vs $-0.05beat
  • Tue, May 5$-0.04 vs $0.37miss
  • Wed, Feb 11$0.46 vs $0.43beat
  • Wed, Nov 5$0.80 vs $0.51beat
  • Tue, Aug 5$0.12 vs $0.00beat
  • Wed, May 7$0.74 vs $0.58beat

Estimates and results for QDEL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

QDELhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newszacks.com·5d ago·Neutral

    QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

    View source ↗